CD4 and neoplasm: To detect and phenotype breast tumor specific CD4+ Treg and Tcon cells by flow cytometry, we had previously developed MHC II tetramers (HLADR 04:01 and HLADR 07:01) loaded with MHC-allele restricted peptides derived from the breast tumor associated antigen mammaglobin I [13].